{"id":"https://openalex.org/W2062321935","doi":"https://doi.org/10.1007/s13300-013-0027-x","title":"Experience with Vildagliptin in Patients \u226575 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment","display_name":"Experience with Vildagliptin in Patients \u226575 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-02","ids":{"openalex":"https://openalex.org/W2062321935","doi":"https://doi.org/10.1007/s13300-013-0027-x","mag":"2062321935","pmid":"https://pubmed.ncbi.nlm.nih.gov/23821355","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3889331"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-013-0027-x","doi":"https://doi.org/10.1007/s13300-013-0027-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0027-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0027-x.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2062321935"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0027-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007864342","display_name":"Anja Schweizer","orcid":"https://orcid.org/0000-0001-8787-3442","observed_orcids":["https://orcid.org/0000-0001-8787-3442"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Anja Schweizer","raw_affiliation_strings":["Novartis Pharma AG, Postfach, 4002, Basel, Switzerland, anja.schweizer@novartis.com","Novartis Pharma AG, Basel, SWITZERLAND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Postfach, 4002, Basel, Switzerland, anja.schweizer@novartis.com","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel, SWITZERLAND","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025969627","display_name":"Sylvie Dejager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092929","display_name":"Novartis (France)","ror":"https://ror.org/00geypp27","country_code":"FR","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210092929"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sylvie Dejager","raw_affiliation_strings":["Novartis Pharma S.A.S, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma S.A.S, Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210092929"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007864342"],"corresponding_institution_ids":["https://openalex.org/I1283582996"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":2.9329,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.90868216,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"4","issue":"2","first_page":"257","last_page":"267"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9660000205039978},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8220000267028809},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9319999814033508},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9459999799728394},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9160000085830688},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9369999766349792},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9419999718666077},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7279999852180481},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9079999923706055},{"id":"https://openalex.org/keywords/weight-stability","display_name":"weight stability","score":0.5019999742507935},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.7450000047683716},{"id":"https://openalex.org/keywords/frail-older-patients","display_name":"frail elderly patients","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.9766845703125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9083025455474854},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.723886251449585},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6728183031082153},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4687386155128479},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32674601674079895},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.29097968339920044}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1007/s13300-013-0027-x","doi":"https://doi.org/10.1007/s13300-013-0027-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0027-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0027-x.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2876922","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3889331","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:23821355","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23821355","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3889331","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3889331/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.795.4569","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.795.4569","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/cb/8f/13300_2013_Article_27.PMC3889331.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s13300-013-0027-x","doi":"https://doi.org/10.1007/s13300-013-0027-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0027-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0027-x.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2062321935.pdf","grobid_xml":"https://content.openalex.org/works/W2062321935.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W97902042","https://openalex.org/W1805640194","https://openalex.org/W1806089932","https://openalex.org/W1968446955","https://openalex.org/W1969235489","https://openalex.org/W1972565816","https://openalex.org/W1983130067","https://openalex.org/W1988358753","https://openalex.org/W2010534563","https://openalex.org/W2014536426","https://openalex.org/W2018521374","https://openalex.org/W2023409610","https://openalex.org/W2028317115","https://openalex.org/W2029378794","https://openalex.org/W2031034414","https://openalex.org/W2033493723","https://openalex.org/W2055753691","https://openalex.org/W2069259691","https://openalex.org/W2072821600","https://openalex.org/W2076573528","https://openalex.org/W2079841945","https://openalex.org/W2088550165","https://openalex.org/W2109077746","https://openalex.org/W2111876001","https://openalex.org/W2129064931","https://openalex.org/W2146702281","https://openalex.org/W2158927982","https://openalex.org/W2411539137","https://openalex.org/W2789732774","https://openalex.org/W2904387867","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2154277743","https://openalex.org/W2079841945","https://openalex.org/W2129064931","https://openalex.org/W2014536426","https://openalex.org/W603325110","https://openalex.org/W3135879765","https://openalex.org/W2041950907","https://openalex.org/W2140047096","https://openalex.org/W3029763447"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Patients":[1],"with":[2,48,50,56,94,140,167,190,206,213,220,271,284],"type":[3],"2":[4],"diabetes":[5],"(T2DM)":[6],"are":[7,38],"at":[8,248],"increased":[9,192],"risk":[10,68,193],"for":[11],"renal":[12,24],"impairment":[13],"(RI)":[14],"and,":[15],"in":[16,23,41,64,92,163,184,254,287,299],"addition,":[17],"there":[18],"is":[19,32],"an":[20,191],"age-related":[21],"decline":[22],"function.":[25],"At":[26],"the":[27,51,66,82,87,196,288,296],"same":[28],"time,":[29],"T2DM":[30,95,141,272],"treatment":[31,36],"more":[33,39,70],"complex":[34],"and":[35,69,84,130,142,208,241,273,282],"options":[37],"limited":[40],"elderly":[42,267],"patients":[43,47,93,122,255,259],"as":[44,46],"well":[45,280],"RI,":[49,277],"patient":[52],"population":[53,268],"\u226575":[54,96,134,269],"years":[55,97,135,270],"moderate":[57,101,143,274],"or":[58,102,144,251,275],"severe":[59,71,103,145,276],"RI":[60,146],"posing":[61],"unique":[62],"challenges,":[63],"particular,":[65],"high":[67],"consequences":[72],"of":[73,78,86,109,174,194,198,290],"hypoglycemia.":[74],"It":[75],"was,":[76],"therefore,":[77],"interest":[79],"to":[80,125,132,236,293],"assess":[81],"efficacy":[83],"tolerability":[85],"dipeptidyl":[88],"peptidase-4":[89],"inhibitor":[90],"vildagliptin":[91,126,168,207,221,257,278],"who":[98],"also":[99],"have":[100],"RI.":[104],"METHODS:":[105],"In":[106,263],"this":[107,264],"sub-analysis":[108],"data":[110],"derived":[111],"from":[112,171],"a":[113,172,249],"previously":[114],"described":[115],"randomized,":[116],"double-blind,":[117],"parallel-group,":[118],"24-week":[119],"study,":[120],"105":[121],"(50":[123],"randomized":[124],"50":[127],"mg":[128],"qd":[129],"55":[131],"placebo)":[133],"(mean":[136,147],"age":[137],"~78":[138],"years)":[139],"baseline":[148,173],"estimated":[149],"glomerular":[150],"filtration":[151],"rate":[152,197,289],"~35":[153],"ml/min/1.73":[154],"m(2))":[155],"were":[156,246],"included.":[157],"RESULTS:":[158],"The":[159],"adjusted":[160],"mean":[161],"change":[162],"glycated":[164],"hemoglobin":[165],"(HbA1c)":[166],"was":[169,187,201,279],"-1.0%":[170],"7.8%":[175],"(between-group":[176],"difference":[177],"-0.8%;":[178],"p":[179],"<":[180],"0.001).":[181],"This":[182],"improvement":[183,298],"glycemic":[185,300],"control":[186],"not":[188],"associated":[189],"hypoglycemia;":[195],"confirmed":[199],"hypoglycemia":[200,291],"0.49":[202],"events":[203,210,224],"per":[204,211],"patient-year":[205,212],"0.96":[209],"placebo":[214,294],"(not":[215],"significant).":[216],"Weight":[217],"remained":[218],"stable":[219],"treatment.":[222],"Adverse":[223],"(AEs)":[225],"(58.0%":[226],"vs.":[227,232,239,244],"72.7%),":[228],"serious":[229],"AEs":[230,237],"(14.0%":[231],"16.4%),":[233],"discontinuations":[234],"due":[235],"(4.0%":[238],"9.1%)":[240],"deaths":[242],"(0%":[243],"5.5%)":[245],"reported":[247],"comparable":[250],"lower":[252],"frequency":[253],"receiving":[256,260],"versus":[258],"placebo.":[261],"CONCLUSION:":[262],"uniquely":[265],"fragile":[266],"tolerated":[281],"efficacious,":[283],"no":[285],"increase":[286],"compared":[292],"despite":[295],"marked":[297],"control.":[301]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2062321935","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
